The potential therapeutic value of CDK6 inhibitors in critical COVID-19
While drug repurposing has been explored in the context of the current coronavirus disease 2019 (COVID-19) pandemic, the success of […]
While drug repurposing has been explored in the context of the current coronavirus disease 2019 (COVID-19) pandemic, the success of […] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To date, […]Antiviral Drug
The potential therapeutic value of CDK6 inhibitors in critical COVID-19
Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo
Copyright © 2024